Clinical Trial Update: TruFreeze™ Airway Obstruction: TAO STUDY [Phase 4]

View source ↗

Summary

CSA Medical's TAO Study of TruFreeze for airway obstruction in obstructive lung disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Airway Obstruction
• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• TruFreeze

Snippet

Sponsor: CSA Medical, Inc. | Conditions: Lung Disease Airways, Lung Diseases, Obstructive | Phase 4 | Status: WITHDRAWN